Vaginitis Screening Assays Market

Future Market Insights

Key Insight

The vaginitis screening assays market is projected to grow from USD 235.4 million in 2026 to USD 463.1 million by 2036, at a CAGR of 7.0%. Molecular PCR assays will dominate with a 45.0% market share, while bacterial vaginosis will lead the application segment with a 40.0% share.

December 18, 2025

Anurag Sharma

250 Pages

Cite this Report

Vaginitis Screening Assays Market

https://www.futuremarketinsights.com/reports/vaginitis-screening-assays-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Cepheid
Hologic
QuidelOrtho Corporation
Siemens

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Vaginitis Screening Assays Market

Key Players

Similar Industry Reports